Valuation UCB

Stocks

Real-time Euronext Bruxelles Other stock markets 08:21:05 06/08/26 pm AEST			5-day change	1st Jan Change
228.80 ^EUR	-0.17%		+5.44%	-4.11%

06/08	UCB Publishes Results Of Post Hoc Data Analysis Of Fintepla In Patients With Lennox-Gastaut Syndrome	CI
01/08	UCB SA, H1 2026 Earnings Call, Jul 30, 2026

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,947	13,973	14,969	36,464	45,333	43,700	-	-
Change	-	-26.25%	7.12%	143.6%	24.32%	-3.6%	-	-
Enterprise Value (EV) ¹	19,807	15,973	17,146	37,918	45,326	43,928	41,760	39,171
Change	-	-19.36%	7.34%	121.15%	19.54%	-3.08%	-4.94%	-6.2%
P/E	17.9x	33.4x	44.8x	34.3x	29.1x	23.3x	18.9x	15.4x
PBR	2.32x	1.58x	1.67x	3.64x	4.18x	3.7x	3.2x	2.64x
PEG	-	-0.6x	-2.2x	0x	0.6x	1.2x	0.8x	0.7x
Capitalization / Revenue	3.28x	2.53x	2.85x	5.93x	5.86x	5.05x	4.51x	4.05x
EV / Revenue	3.43x	2.9x	3.26x	6.16x	5.86x	5.08x	4.31x	3.63x
EV / EBITDA	12.1x	12.7x	12.7x	25.7x	17.2x	14.8x	11.4x	9.07x
EV / EBIT	15x	23.7x	26.1x	45.4x	22.6x	18x	13.9x	10.6x
EV / FCF	15.6x	18.4x	38.5x	41.2x	24.6x	20.7x	15.7x	12.4x
FCF Yield	6.42%	5.43%	2.6%	2.43%	4.06%	4.83%	6.35%	8.09%
Dividend per Share ²	1.3	1.33	1.36	1.39	1.45	1.457	1.502	1.534
Rate of return	1.3%	1.81%	1.72%	0.72%	0.61%	0.64%	0.66%	0.67%
EPS ²	5.6	2.2	1.76	5.61	8.2	9.85	12.11	14.92
Distribution rate	23.2%	60.5%	77.3%	24.8%	17.7%	14.8%	12.4%	10.3%
Net sales ¹	5,777	5,517	5,252	6,152	7,741	8,650	9,700	10,801
EBITDA ¹	1,641	1,260	1,349	1,476	2,636	2,975	3,654	4,318
EBIT ¹	1,318	675	657	836	2,009	2,438	3,005	3,707
Net income ¹	1,058	418	343	1,065	1,558	1,873	2,342	2,870
Net Debt ¹	860	2,000	2,177	1,454	-7	228.2	-1,940	-4,529
Reference price ²	100.35	73.56	78.90	192.20	238.60	229.20	229.20	229.20
Nbr of stocks (in thousands)	188,812	189,959	189,721	189,720	189,996	190,663	-	-
Announcement Date	24/2/22	22/2/23	28/2/24	27/2/25	24/2/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
UCB	23.27x	5.08x	14.76x	0.64%	50.46B
REGENERON PHARMACEUTICALS, INC.	18.15x	4.14x	9.73x	0.51%	76.75B
SAMSUNG BIOLOGICS CO.,LTD.	36.31x	12.41x	23.62x	-.--%	48.5B
CSL LIMITED	-59.22x	3.44x	10.16x	3.1%	44.14B
BIOGEN INC.	37.6x	3.42x	12.82x	-.--%	30.53B
INCYTE CORPORATION	53.46x	3.37x	26.12x	-.--%	24.28B
MODERNA, INC.	-6.56x	8.93x	-5.76x	-.--%	22.46B
INNOVENT BIOLOGICS, INC.	68.17x	6.51x	43.28x	-.--%	20.04B
BRIDGEBIO PHARMA, INC.	-36.51x	17.55x	-48.02x	-.--%	16.03B
SWEDISH ORPHAN BIOVITRUM AB	23.1x	4.97x	12.95x	-.--%	16.14B
Average	15.78x	6.98x	9.97x	0.42%	34.93B
Weighted average by Cap.	14.79x	6.32x	12.28x	0.6%